I’ve nothing new to report about myself, but I’m very excited about an article my daughter-in-law sent to me last night.
It seems that in the UK they’ve developed a blood test that can determine some cancer patients’ chances of relapse/recurrence up to 7.9 months before the cancer becomes detectable via scans or biopsies. The promising “liquid biopsy” is being developed at the Institute of Cancer Research in London.
Researchers say the test “can detect an individual’s specific ‘circulating tumor DNA,’ or ctDNA, matched to the cancer for which they were treated.”
The team plans a larger study next year (the one being reported had 55 subjects) and it could be several years before the test becomes widely available to cancer survivors. I expect and intend to be one of those survivors, and I know the doctors will be watching me closely for at least 5 years for any possible recurrence of my cancer. Imagine, a simple blood test that can detect a recurrence months before any currently available detection method! So exciting, for so many millions of cancer survivors around the world.
But a word of caution. Further reading reveals things are not as simple as they might seem. Do your research. Lots of research.